Henry Ellenbogen’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299M Sell
11,635,948
-451,895
-4% -$10.5M 2.91% 13
2026
Q1
$249M Hold
12,087,843
2.56% 17
2025
Q4
$287M Buy
12,087,843
+396,158
+3% +$9.64M 2.71% 15
2025
Q3
$291M Buy
11,691,685
+203,842
+2% +$4.39M 2.16% 21
2025
Q2
$264M Hold
11,487,843
2% 21
2025
Q1
$258M Hold
11,487,843
2.3% 19
2024
Q4
$225M Buy
11,487,843
+378,255
+3% +$7.5M 1.83% 21
2024
Q3
$202M Buy
11,109,588
+2,018,679
+22% +$38.5M 1.48% 27
2024
Q2
$158M Hold
9,090,909
1.3% 31
2024
Q1
$178M Hold
9,090,909
1.38% 25
2023
Q4
$209M Hold
9,090,909
1.65% 21
2023
Q3
$209M Hold
9,090,909
1.91% 20
2023
Q2
$237M Buy
+9,090,909
New +$240M 2.08% 22

Other funds holding PRVA

Henry Ellenbogen's PRVA Position: Q2 2026 in Review

Henry Ellenbogen reduced its Privia Health (PRVA) stake by 3.7% in Q2 2026, selling an estimated $10.5M and leaving 11,635,948 shares worth $299M. The position accounts for 2.91% of the portfolio, ranked #13.

Henry Ellenbogen first reported a position in PRVA in Q2 2023 and has held it in 13 quarters since. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Henry Ellenbogen held 11,635,948 shares of Privia Health worth $299M as of Q2 2026.
  • Henry Ellenbogen sold 451,895 Privia Health shares in Q2 2026, an estimated $10.5M.
  • Privia Health made up 2.91% of Henry Ellenbogen's portfolio in Q2 2026, its #13 holding.
  • Henry Ellenbogen first reported a position in Privia Health in Q2 2023 and has held it in 13 quarters since.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Durable Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.